News

Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals from continental Africa. Their work addresses a long-standing gap by studying a population grossly underrepresented in…

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and international partner institutions have generated one of the most detailed cellular maps of carotid artery plaques to date. Their work shows how different cell types and…

The European Commission has appointed Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, to the Scientific Council of the European Research Council (ERC). Alongside five newly selected members, she will…

Researchers at Helmholtz Munich have found that the body begins signaling the risk of type 2 diabetes many years before the disease is diagnosed. In a long-term study, the team examined hundreds of blood metabolites – small molecules that reflect…

Helmholtz Munich is part of the EU research initiative PROBE, which aims to fundamentally transform the way osteoarthritis is diagnosed and treated. The project is funded through HORIZON EUROPE by the Innovative Health Initiative and has a total…

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

News

Mapping Proteins in African Genomes Reveals New Paths to Fight Type 2 Diabetes

Mapping Carotid Artery Plaques at Single-Cell Resolution

Eleftheria Zeggini Appointed to ERC Scientific Council

Tracking Metabolic Clues Years Before Type 2 Diabetes Develops

Helmholtz Munich Launches Pioneering Osteoarthritis Research Project With EU Partners

Helmholtz Munich to Advance AI Benchmarking With Three Newly Funded Projects